Bronkhial'naya astma u detey. Dostizhenie kontrolya i predotvrashchenie obostreniy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Prevalence of allergic diseases continues to grow, and bronchial asthma remains one of the most widespread allergic pathologies among younger and older children. Timely administration of background therapy helps to reduce the risk of seeking for emergency medical care associated with the worsening of the disease and the frequency of readmissions. For preschool children, nebulizer is the one of the best means for delivery of inhaled corticosteroids in exacerbation of the disease, and for the background treatment.

Full Text

Restricted Access

References

  1. Аллергия у детей: от теории - к практике / Под ред. Л.С. Намазовой-Барановой. М., 2010-2011. 668 с.
  2. http://www.cdc.gov/nchs/fastats/asthma.htm
  3. Намазова-Баранова Л.С., Огородова Л.М., Томилова А.Ю., и др. Распространенность астмаподобных симптомов и диагностированной астмы в популяции подростков. Педиатрическая фармакология. 2009; 6(3): 59-65.
  4. Вишнева Е.А., Намазова-Баранова Л.С., Алексеева А.А., и др. Детская астма: ключевые принципы достижения контроля на современном этапе. Педиатрическая фармакология. 2013; 10(4): 60-72.
  5. Papadopoulos N.G., Arakawa H., Carlsen K.-H., et al. International consensus on (ICON) pediatric asthma. Allergy. 2012; 67: 976-97.
  6. Куличенко Т.В., Намазова-Баранова Л.С., Торшхоева Р.М., и др. Анти-ІдЕ-терапия тяжелой бронхиальной астмы у детей: двухлетний опыт. Педиатрическая фармакология. 2010; 7(3): 57-65.
  7. Stevens M.W., Gorelick M.H. Short-term outcomes after acute treatment of pediatric asthma. Pediatrics. 2001; 107: 1357-62.
  8. Вишнева Е.А., Намазова-Баранова Л.С. Бронхиальная астма у детей младше 8 лет: как снизить частоту обострений и госпитализаций? Педиатрическая фармакология. 2009; 6(1): 51-4.
  9. Bloomberg G.R., Trinkaus K.M., Fisher E.B. Jr, et al. Hospital readmissions for childhood asthma: a 10-year metropolitan study. Am. J. Respir. Crit. Care Med. 2003; 167: 1068-76.
  10. Mitchell E.A., Bland J.M., Thompson J.M. Risk factors for readmission to hospital for asthma in childhood. Thorax. 1994; 49: 33-6.
  11. Schaubel D., Johansen H., Mao Y., et al. Risk of preschool asthma: incidence, hospitalization, recurrence, and readmission probability. J. Asthma. 1996; 33: 97-103.
  12. Weiss K.B., Gergen P.J., Hodgson T.A. An economic evaluation of asthma in the United States. N. Engl. J. Med. 1992; 326: 862-66.
  13. Donahue J.G., Weiss S.T., Livingston J.M., et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997; 277: 887-91.
  14. Sin D.D., Man S.F. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch. Intern. Med. 2002; 162: 1591-95.
  15. Stempel D.A., Pinto L., Stanford R.H. The risk of hospitalization in patients with asthma switched from an inhaled corticosteroid to a leukotriene receptor antagonist. J. Allergy Clin. Immunol. 2002; 110: 39-41.
  16. Suissa S., Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J. Allergy Clin. Immunol. 2001; 107: 937-44.
  17. Kofman C., Berlinski A., Zaragoza S., et al. Aerosol therapy for pediatric outpatients. J. Respir. Care Practitioners. 2004. Available from http://www.rtmagazine. com/issues/articles/2004-03_05.asp [Last accessed April 18, 2007].
  18. McLaughlin T., Leibman C. Risk of recurrent emergency department visits or hospitalizations in children with asthma receiving nebulized budesonide inhalation suspension compared with other asthma medications. Current Medical Res. Opinion. 2007; 23(6): 1319-28.
  19. Baker J.W., Mellon M., Wald J., et al. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants. Pediatrics. 1999; 103(2): 414-21.
  20. Shapiro G., Mendelson L., Kraemer M.J., et al. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. J. Allergy Clin. Immunol. 1998; 102: 789-96.
  21. Turpeinen M., HEICA Study Group. Helsinki Early Intervention Childhood Asthma (HEICA) study: Inhaled budesonide halved the number of asthma exacerbations compared with inhaled disodium cromoglycate during 18 months of treatment. Eur. Respir. J. 2000; 16: 311.
  22. Szefler S.J., Eigen H. Budesonide inhalation suspension: a nebulized corticosteroid for persistent asthma. J. Allergy Clin. Immunol. 2002; 109(4): 730-42.
  23. Guilbert T.W., Morgan W.J., Zeiger R.S., et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. NEJM. 2006; 354: 1985-97.
  24. Авдеев С.Н., Бродская О.Н. Стери-Небы - новые возможности небулайзерной терапии обструктивных заболеваний легких. Научное обозрение респираторной медицины. 2011;3:18.
  25. Баранов А.А., Вишнева Е.А., Намазова-Баранова Л.С. Телемедицина - перспективы и трудности перед новым этапом развития. Педиатрическая фармакология. 2013; 10(3): 6-11

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies